Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Free Communications

Management of Disorders of Insulin Secretion

The Anti-diabetic Drug, Metformin, Suppresses Adipogenesis through both AMP-activated Protein Kinase (AMPK)-dependent and AMPK-independent Mechanisms
aDevelopmental Endocrinology Research Group, School of Medicine, University of Glasgow, Glasgow, UK; bInstitute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, UK; cInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; dINSERM, U1016, Institut Cochin, Université Paris Descartes, Paris, France; eInstitute of Biological Chemistry, Biophysics and Bioengineering, Edinburgh Campus, Heriot-Watt University, Edinburgh, UK
hrp0086fc5.1
Diabetes and Insulin Injection Modalities: Effects on Hepatic Expression and Activity of 11[beta]-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Rats
aUniversité Bordeaux, Nutrition et Neurobiologie Intégrée, Bordeaux, France; bCHU Bordeaux, Hôpital des Enfants, Bordeaux, France; cINRA, Nutrition et Neurobiologie intégrée, Bordeaux, France; dLaboratoire de Biochimie de l’Hôpital Haut-Lévêque, Pessac, France; eINSERM U1026 BioTis, Bordeaux, France
hrp0086fc5.2
Glibentek, a New Suspension of Glibenclamide for Patients with Neonatal Diabetes, is as Effective and more Convenient than Crushed Tablets
aUnité d’endocrinologie, gynécologie et diabétologie pédiatrique, Hôpital universitaire Necker - Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France; bFaculté de Médecine Paris Descartes, Université Sorbonne Paris Cité, Paris, France; cLaboratoire de Pharmacologie -Toxicologie, Hôpital Maison Blanche, CHU Reims, Reims, France; dService de pédiatrie, CHU Nantes, Nantes, France; ePédiatrie, diabétologie, CHU Toulouse Purpan, Toulouse, France; fService de pédiatrie, CHU Brest, Brest, France; gService de pédiatrie médicale, CHU Caen, Caen, France; hService de pédiatrie, Hôpital Jeanne De Flandres, Lille, France; iService de pédiatrie, Hôpital Jacques Monod, Montivilliers, France; jUnité de recherche clinique, centre d’investigation Clinique, Hôpital universitaire Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris, France
hrp0086fc5.3
Persistent Beneficial Metabolic Effect after Five Years in a Cohort of 28 Subjects with Neonatal Diabetes owing to Potassium Channel Mutation and Transferred from Insulin to Sulfonylureas
aUnité d’endocrinologie, gynécologie et diabétologie pédiatrique, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; bFaculté de médecine Paris Descartes, Université Sorbonne Paris Cité, Paris, France; cUnité de recherche clinique, centre d’investigation Clinique, Hôpital universitaire Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris, France; dInserm U1016, Institut Cochin, Paris, France; eDépartement de génétique, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Robert Debré, Paris, France
hrp0086fc5.4
Impact of Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections on Bone Health in Children and Adolescents with Type 1 Diabetes
aDepartment of Biomedical Sciences and Human Oncology, Pediatrics Unit, University of Bari “A. Moro”, Bari, Italy; bDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Human Anatomy and Histology, University of Bari “A. Moro”, Bari, Italy; cDepartment of Emergency and Organ Transplantation, University of Bari “A. Moro”, Bari, Italy
hrp0086fc5.6